statistiche ricercatore

Continente	#
NA - Nord America	698
EU - Europa	523
AS - Asia	398
SA - Sud America	45
AF - Africa	14
Continente sconosciuto - Info sul continente non disponibili	11
OC - Oceania	1
Totale	1.690

Nazione	#
US - Stati Uniti d'America	681
RU - Federazione Russa	201
SG - Singapore	169
GB - Regno Unito	131
CN - Cina	116
IT - Italia	58
VN - Vietnam	37
BR - Brasile	35
HK - Hong Kong	27
SE - Svezia	26
DE - Germania	24
FR - Francia	20
FI - Finlandia	19
IE - Irlanda	19
CA - Canada	14
KR - Corea	13
BD - Bangladesh	6
ES - Italia	6
NG - Nigeria	5
UA - Ucraina	5
AR - Argentina	4
EC - Ecuador	4
IN - India	4
PL - Polonia	4
TR - Turchia	4
IQ - Iraq	3
NL - Olanda	3
NP - Nepal	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
CW - ???statistics.table.value.countryCode.CW???	2
ET - Etiopia	2
JP - Giappone	2
MX - Messico	2
AL - Albania	1
AU - Australia	1
BG - Bulgaria	1
BJ - Benin	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
EG - Egitto	1
ID - Indonesia	1
IL - Israele	1
IM - Isola di Man	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MA - Marocco	1
MN - Mongolia	1
MY - Malesia	1
OM - Oman	1
PK - Pakistan	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SY - Repubblica araba siriana	1
TG - Togo	1
TH - Thailandia	1
UZ - Uzbekistan	1
Totale	1.681

Nome	#
Drug-related deaths: analysis of an Italian spontaneous reporting database.	246
Hepatic adverse drug reactions: a case/non-case study in Italy	202
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series	195
Further Insights into the Hematological Disorders Observed in Shwachman-Diamond Syndrome: mTOR and STAT3 Hyper-Phosphorylation in CD4+ and CD8+ T Cells and Efficacy of Rapamycin Treatment	188
Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database	177
Quality control of coding in a spontaneous reporting database: is it necessary?	172
Recognition of drug interactions using General Practitioners database	167
The influence of Notoriety Bias on ADR Spontaneous Rate	157
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation	141
Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program	45
Totale	1.690

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	24	0	0	0	0	2	0	0	5	1	1	1	14
2022/2023	129	7	9	16	17	15	27	3	9	18	0	4	4
2023/2024	79	3	6	6	9	14	9	1	4	2	11	10	4
2024/2025	180	16	10	17	29	11	3	6	2	37	10	15	24
2025/2026	778	40	25	144	96	202	48	68	45	57	34	9	10
2026/2027	142	10	16	37	72	7	0	0	0	0	0	0	0
Totale													1.690

CATALOGO DEI PRODOTTI DELLA RICERCA